30 Day Trial

Zimmer Biomet 3Q17 Orthopaedic Revenue

Share:

ORTHOWORLD estimates Zimmer Biomet 3Q17 orthopaedic revenue of US $1,694.5MM, -0.7% from 3Q16, and YTD revenue of $5,346.6MM, +2.3% vs. the prior year.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.